Evaluating the Comparative Safety and Immunogenicity of Three Lots of Novartis Meningococcal C Conjugate Vaccine in Healthy Toddlers

Clinical trial NCT01434680 · COMPLETED

Trial details

NCT number: NCT01434680
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Meningococcal Disease Meningococcal Meningitis

Start date: 2011-09-01
Primary completion: 2012-11-01
Enrollment: 992

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.